.RESEARCH FEATURE.19 September 2024. Plozasiran reduced triglyceride amounts by 80% and decreased the risk of pancreatitis in individuals along with chronic chylomicronemia, along with or even without a genetic prognosis.
Your daily update on everything worldwide—from news and finance to technology, health, and lifestyle.
.RESEARCH FEATURE.19 September 2024. Plozasiran reduced triglyceride amounts by 80% and decreased the risk of pancreatitis in individuals along with chronic chylomicronemia, along with or even without a genetic prognosis.